These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3497727)

  • 1. The regulation by low-density lipoproteins of the activation of oxidative enzyme-primed lymphocytes is governed by transferrin.
    Scupham DW; McCarthy BM; Harmony JA
    Cell Immunol; 1987 Sep; 108(2):378-95. PubMed ID: 3497727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphatidylinositol response and proliferation of oxidative enzyme-activated human T lymphocytes: suppression by plasma lipoproteins.
    Akeson AL; Scupham DW; Harmony JA
    J Lipid Res; 1984 Nov; 25(11):1195-205. PubMed ID: 6335165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective activation of T8+ cells by neuraminidase and galactose oxidase is mediated by activated T4+ cells.
    Akeson AL; Harmony JA
    Exp Cell Res; 1987 May; 170(1):129-46. PubMed ID: 3494623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.
    Cuthbert JA; Lipsky PE
    J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins can suppress accessory cell function and consequently suppress lymphocyte activation.
    Nakayasu T; Macy M; Okano Y; McCarthy BM; Harmony JA
    Exp Cell Res; 1986 Mar; 163(1):103-16. PubMed ID: 2935417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human lymphocyte responses by low density lipoproteins (LDL): enhancement but not immunosuppression is mediated by LDL receptors.
    Cuthbert JA; Lipsky PE
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4539-43. PubMed ID: 6087331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression.
    Kumagai N; Benedict SH; Mills GB; Gelfand EW
    J Immunol; 1988 Jan; 140(1):37-43. PubMed ID: 3121740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.
    Novogrodsky A; Suthanthiran M; Saltz B; Newman D; Rubin AL; Stenzel KH
    J Exp Med; 1980 Mar; 151(3):755-60. PubMed ID: 7359085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessory cells induce a polyphosphatidylinositol response when cultured with mitogen-activated T lymphocytes.
    Akeson AL; Mitani K; McCarthy BM; Harmony JA
    J Cell Physiol; 1990 Nov; 145(2):356-64. PubMed ID: 2246334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line.
    McCarthy BM; Okano Y; Nakayasu T; Macy M; Watson SR; Harmony JA
    J Lipid Res; 1987 Sep; 28(9):1067-77. PubMed ID: 3498779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins may provide fatty acids necessary for human lymphocyte proliferation by both low density lipoprotein receptor-dependent and -independent mechanisms.
    Cuthbert JA; Lipsky PE
    J Biol Chem; 1989 Aug; 264(23):13468-74. PubMed ID: 2760030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
    Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding.
    Rigby WF; Hamilton BJ; Waugh MG
    Cell Immunol; 1990 Feb; 125(2):396-414. PubMed ID: 2105168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mitogen-induced metabolic events essential to proliferation of human T lymphocytes: dependence of specific events on the influence of adherent accessory cells.
    Bruszewski WB; Bruszewski JA; Tonnu H; Ferezy SL; O'Brien RL; Parker JW
    J Immunol; 1984 Jun; 132(6):2837-43. PubMed ID: 6609961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential fatty acids and iron are involved at distinct stages of the proliferative cycle but not in the activation of human T cells.
    Or R; Kovar J; Domenico J; Gelfand EW
    Clin Immunol Immunopathol; 1992 Mar; 62(3):314-20. PubMed ID: 1371729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of neuraminidase and galactose oxidase on murine lymphocytes. I. Evidence for the differential delivery of signal(s) leading to cell proliferation and the differentiation of cytotoxic T cells.
    Kuppers RC; Henney CS
    J Immunol; 1977 Dec; 119(6):2163-71. PubMed ID: 303259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligodeoxynucleotides for IL-2, c-myc and transferrin receptor synchronize mitogen-activated lymphocytes in the G1 phase.
    Kato J; Kohgo Y; Kondo H; Sasaki K; Niitsu Y
    Scand J Immunol; 1994 May; 39(5):499-504. PubMed ID: 8191225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
    Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
    J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenic properties of neuraminidase and galactose oxidase-treated lymphoblastoid cells and plasma membranes for peripheral blood lymphocytes.
    Arnold A; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Nov; 133(5):2569-76. PubMed ID: 6332856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.